Abbott Diabetes Care is developing products to reduce the discomfort and inconvenience of blood glucose monitoring: introducing systems that are easier to use, require less blood and provide faster results.

Based in Alameda, California, Abbott Diabetes Care designs, develops and manufactures several leading-edge glucose monitoring systems and test strips for use in both home and hospital settings. Among its leading friends are the FreeStyle Lite™ system, the FreeStyle Flash^® system, the FreeStyle Freedom^® system and the Precision Xtra^® system.

In addition to monitoring systems and diabetes management products, Abbott Diabetes Care also focuses on educating people with diabetes on how they can make every day the choices to help themselves - and live active, healthy lives.

Abbott Diabetes Care History

Abbott entered the blood glucose monitoring marketplace with the acquisition of MediSense in 1996. In April 2004, Abbott announced it had completed the acquisition of TheraSense, a leader in developing blood glucose self-monitoring devices that require very small blood samples to deliver rapid test results. Virtually Pain Free. The TheraSense acquisition strengthened Abbott's position in the large and growing blood glucose monitoring market.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture, and marketing of pharmaceuticals and medical products, including nutritionals, devices, and diagnostics. The company employs more than 65,000 people and markets its products in more than 130 countries.